Activation of nuclear factor-B (NF-B) can promote or inhibit apoptosis. Oxidative stress is an important mechanism by which certain anticancer drugs kill cancer cells, and is also one of the mechanisms that activate NF-B. We therefore examined hepatic expression of the NF-B monomer p65 in human hepatocellular carcinoma (HCC) tissue samples from eight patients and compared it with their respective samples of surrounding liver tissues. We also studied the effect of NF-B inhibition in human HCC cells exposed to oxida 
INTRODUCTION O
NE OF THE MAJOR CHALLENGES in cancer treatment is the resistance of tumor cells to therapy-induced apoptosis, which is considered to be the major mode of cell death with chemotherapeutic agents or radiation therapy. Hepatocellular carcinoma (HCC) is one of the most common hepatic malignancies worldwide, and its incidence in the United States and Australia has risen (El-Serag and Mason, 1999; Law et al., 2000) . Because of the poor effects of current treatment modalities, novel approaches of treating HCC are needed.
Oxidative stress is one of the mechanisms by which radiation therapy and certain cancer therapeutic drugs kill cancer cells. The mechanisms include suppression of cell proliferation and triggering of cell death, either by apoptosis or necrosis depending on the cellular context and cell type. Nuclear factor-B (NF-B) is a redox-sensitive transcription factor that is universally present in all eukaryotic cells. The 90 or so genes that are governed by NF-B include cytokines and proinflammatory molecules, cell cycle genes, and genes that either activate and facilitate cell death process, or oppose it and provide cellular protection. To avoid inappropriate unleashing of such a biologically pivotal set of consequences, NF-B is normally kept inactive in the cytoplasm by binding to inhibitory proteins such as IB (Karin, 1999) . Many agents or stimuli such as cytokines, bacterial products (lipopolysaccharide [LPS] ), viruses (e.g., hepatitis C virus [HCV] infection) and their proteins, partial hepatectomy, tumor necrosis factor-␣ (TNF-␣), chemotherapeutic agents, and radiation therapy can activate NF-B. On stimulation, IB is phosphorylated at two NH 2 -terminal serine residues (S 32 and S 36 ) by an IB kinase (IKK) complex; this permits ubiquitination and targeting to the 26S proteasome (Henkel et al., 1993; Palombella et al., 1994) , where the complex is cleaved to liberate NF-B dimers. These dimeric complexes of NF-B proteins are free to enter the nucleus and bind to recognition sites that either stimulate or inhibit transcription of the target genes (Brown et al., 1995) .
In many cell types, particularly cancer cells, NF-B is a potent antiapoptotic factor. Deregulation of apoptosis has been implicated in the pathogenesis of HCC complicating chronic hepatitis B virus (HBV) and HCV infection (Bantel and Schulze-Osthoff, 2003; Staib et al., 2003) . However, the underlying mechanisms by which apoptosis is downregulated in the pathogenesis of HCC are incompletely understood. The effects of NF-B modulation on cell survival depend on both the cell type and the nature of NF-B inducer (Barkett and Gilmore, 1999) . Thus, inactivation of NF-B sensitizes hepatocytes to TNF-induced apoptosis (Van Antwerp et al., 1996) , whereas after partial hepatectomy, TNF-mediated activation of NF-B is required for hepatocyte survival and progression into the cell cycle Webber et al., 1998; Plumpe et al., 2000) . On the other hand, inhibition of NF-B by its superrepressor during experimental obstructive cholestasis does not affect the rate of apoptosis (Bird et al., 2003) , and actually suppresses hepatic DNA synthesis. In cancer cells, the role of NF-B inhibition remains even more controversial. Several reports have demonstrated that NF-B inhibition can sensitize cancer cells, leading to their death by anticancer drugs (Van Antwerp et al., 1996; Wang et al., 1996 Wang et al., , 1999 Feig et al., 1999; Patel et al., 2000; Arlt et al., 2001) , whereas others found that suppression of NF-B function failed to change the sensitivity of cancer cells to therapy (Cai et al., 1997; Li et al., 1997; Bentires-Alj et al., 1999) . In HCC cells, inhibition of NF-B suppresses rather than sensitizes the cells to doxorubicin (Adriamycin)-induced apoptosis (Tietze et al., 2000) , suggesting that NF-B may be proapoptotic rather than antiapoptotic in HCC cells. In our work, however, we demonstrated that rat hepatoma ARL-6 cells were relatively more resistant to prooxidant H 2 O 2 -induced cell killing compared with normal rat hepatocytes, and inhibition of NF-B in ARL-6 cells led to sensitization of these cells to H 2 O 2 -induced apoptosis (Qiao et al., 2005) . NF-B has become a new target of gene therapy in many malignant conditions. Some NF-B modulators, especially those with NF-Binhibitory capabilities, have been investigated for their efficacy in enhancing the apoptotic response to therapeutic agents, such as BAY 11-7082 (Dai et al., 2004) and bortezomib (PS-341) for the treatment of patients with advanced multiple myeloma (Voorhees et al., 2003; Panwalkar et al., 2004) .
In this study, we aimed to examine whether NF-B inhibition by mutant IB␣ (mIB␣) in HuH7 cells (a human HCC cell line) could facilitate the killing effects of the prooxidant H 2 O 2 on these cells. mIB␣ has previous been shown to specifically block NF-B activation in many cell types without affecting other transcription factors Jobin et al., 1998; Feig et al., 1999; Heimberg et al., 2001; Sato et al., 2003) .
The results indicate that abrogation of NF-B activation sensitizes human HCC cells to oxidative stress-induced cell killing and proliferation inhibition.
MATERIALS AND METHODS

Cell culture
HuH7 cells (derived from a human HCC) were obtained from the American Type Culture Collection (Cryosite, Sydney, Australia). They were cultured in Dulbecco's modified Eagle's medium (DMEM; Life Technologies, Melbourne, Australia) supplemented with 10% fetal calf serum (FCS), streptomycin (100 g/ml), penicillin (100 g/ml), and 2 mM L-glutamine in a humidified atmosphere of 5% CO 2 at 37°C.
Hepatic tissues from patients with HCC
We collected malignant (HCC) tissues and their matched surrounding nonmalignant liver tissues from eight patients who had liver resection for HCC. These tissues were from four patients with well-differentiated HCC (samples 1-4) and from four patients with poorly differentiated HCC (samples 5-8), all with negative HBV and HCV serology. Written consent was obtained from each patient before tissue collection.
Infection of HuH7 cells with adenoviral vectors
Adenoviral vectors carrying the IB␣ superrepressor (mIB␣) or ␤-galactosidase (␤-Gal) gene were used in this study. To obtain high-titer viral vectors, 2 ϫ 10 7 HEK293 cells (American Type Culture Collection) were infected at a multiplicity of infection (MOI) of 10. The infected cells were maintained under routine culture conditions for several days until a cytopathic effect was evident. Virus-infected HEK293 cells were collected, and viral particles were released by repeated freeze-thaw cycles. The resultant crude virus preparation was purified with a BD Adeno-X virus purification kit (BD Biosciences Clontech, Sydney, Australia), the optical density at 260 nm (OD 260 ) was measured, and the virus titer was determined, as per the manufacturer's instructions. HuH7 cells were cultured to 60-70% confluence before being incubated for 4 hr in serum-free medium with adenoviral vectors carrying mIB␣ or ␤-Gal. Cells were then cultured in complete growth medium for up to 24 hr to allow adequate expression of the transgenes before commencement of further experiments.
Infection efficiency in cultured HuH7 cells was determined with ␤-Gal as the reporter gene, as described elsewhere (Feig et al., 1999) . The viral infection rate was determined by calculating the number of 5-bromo-4-chloro-3-indolyl-␤-D-galactopyranoside (X-Gal)-stained cells, and by expressing the results as the ratio of X-Gal-positive cells to the total number of cells counted. Infection of cells occurred in the expected dosedependent manner: with viral concentrations Ͻ 200 plaqueforming units (PFU)/cell, HuH7 cells showed virtually no XGal staining, whereas abundant X-Gal-positive cells were observed with increasing viral concentrations. On the basis of the X-Gal staining assay, both ␤-Gal and mIB␣ were used at 5000 PFU/cell in most of the subsequent studies unless otherwise specified. 
Determination of viability
Extraction of cytoplasmic and nuclear proteins
Proteins from cytoplasmic and nuclear fractions of cells were extracted as previously reported (Teoh et al., 2003) . Protein concentrations were estimated with a Bradford protein assay kit (Bio-Rad, Hercules, CA).
Assessment of NF-kB activation
Activation of NF-B was assessed by two complementary methods. Immunofluorescence microscopy was used to examine the translocation of NF-B p65 subunit, as described previously (Birbach et al., 2002) . NF-B DNA-binding activity was determined by electrophoretic mobility shift assay (EMSA), as reported elsewhere (Teoh et al., 2002) . Supershift was not routinely performed with each experiment, as our laboratory has previously confirmed the target identity (Teoh et al., 2002) .
TdT-mediated dUTP nick end-labeling assay
The TdT (terminal deoxynucleotidyltransferase)-mediated dUTP nick end-labeling (TUNEL) assay was performed as previously reported (Qiao et al., 2002 ) with a commercially available assay kit (In Situ cell death detection kit; Roche Diagnostics). Briefly, cells were fixed with 3% paraformaldehyde, incubated with TUNEL reagent for 60 min, rinsed with phosphate-buffered saline (PBS), and incubated with Converter-POD; color was developed by incubation with 3,3Ј-diaminobenzidine (DAB) substrate. After counterstaining with hematoxylin, cells were washed, air dried, mounted, and examined by light microscopy. The number of TUNEL-positive cells was counted and the result expressed as the percentage of positive cells relative to the total number of cells counted.
Determination of protein expression by immunoblotting: Western blot
Sixty micrograms of protein extract from each sample was resolved by sodium dodecyl sulfate-12% polyacrylamide gel electrophoresis (SDS-PAGE) under reducing conditions and electrotransferred onto nitrocellulose membranes (Millipore, Bedford, MA), as previously reported (Teoh et al., 2002) . The membranes were blocked with 5% nonfat milk and probed overnight with primary antibodies against p65, intercellular adhesion molecule-1 (ICAM-1), vascular cell adhesion molecule-1 (VCAM-1), Bax, and Bcl-X L (Santa Cruz Biotechnology, Santa Cruz, CA). Membranes were washed and incubated with species-specific secondary antibodies conjugated with horseradish peroxidase, which were detected with SuperSignal West Pico chemiluminescent substrate (Pierce Biotechnology, Rockford, IL), and exposed to Hyperfilm (Amersham Biosciences, Castle Hill, Sydney, Australia).
Measurement of caspase-3 activity
Caspase-3 activity was analyzed with an ApoAlert caspase-3 kit (BD Biosciences Clontech), which measures proteolytic cleavage of the chromophore p-nitroanilide (pNA). Cells were harvested, washed with PBS, lysed in ice-cold cell lysis buffer, and centrifuged at 14,000 ϫ g for 15 min. Fifty micrograms of supernatant was incubated at 37°C for 3 hr in reaction buffer containing DEVD-pNA. Caspase-3 activity was determined from the count of pNA released, as determined at 405 nm with a Wallac 1420 VICTOR 2 microplate reader (PerkinElmer, Melbourne, Australia).
Assessment of cell proliferation
Cell proliferation was determined by [ 3 H]thymidine incorporation into cellular DNA (Qiao et al., 2001) .
Statistical analyses
Results are presented as means Ϯ SD. Significant differences between groups were determined by Student t test.
RESULTS
Expression level of NF-B in human HCC and nontumorous liver
We compared the expression levels of p65 in eight HCC tissues with their respective levels in surrounding nontumorous liver by Western blot, and revealed that in six patients, p65 was expressed at much higher levels in HCC than in nontumorous tissue (Fig. 1A) . In six liver specimens, the constitutive activation of NF-B p65 was also demonstrated by EMSA (Fig. 1B) . Incidentally, we detected a strong binding complex in the cancerous liver of one patient (Fig. 1B) . The nature of this complex is not clear. In three cases (patients 3, 4, and 6) in which p65 was richly expressed, p65 was also detected in the nuclear compartments of the HCC tissue (but not in nontumorous liver) (Fig. 1C) , indicating constitutive activation. The average expression level of NF-B was not significantly different between well and poorly differentiated HCCs.
Expression level of NF-B in HuH7 cells versus nontumorous liver
As HuH7 cells were derived from human HCC, we also compared the basal expression level of NF-B p65 in this cell type with that in nontumorous tissues obtained from two patients who had liver resection for HCC. By Western blot, p65 was also found to be richly expressed in HuH7 cells compared with two samples of nontumorous tissue (Fig. 1D) . EMSA also demonstrated constitutive activation of NF-B in HuH7 cells compared with noncancerous hepatic tissues (Fig. 1D, arrowhead) .
These data suggested that NF-B is either overexpressed and/or constitutively activated in most HCC tissues.
Infection efficiency of adenoviral vectors in HuH7 cells
On the basis of the above results, we attempted to block NF-B activity in HCC cells by adenovirus-mediated transfer of mIB␣ and to determine whether this construct could facilitate growth inhibition and cell death in response to oxidative stress. Initially, we used three different HCC cell lines: HuH7, HepG2, and Hep3B. As the results obtained from these three cell lines were similar, we performed most of the experiments only in HuH7 cells, and the reported data are mostly from this cell line. To determine the in vitro infection efficiency of HCC cells by mIB␣, we used an adenovirus carrying ␤-galactosidase (␤-Gal) as a reporter to determine the number of successfully infected cells. Figure 2 shows the representative results obtained in HuH7 cells. Twenty-four hours after infection with ␤-Gal adenovirus at various concentrations, cells were viewed by light microscopy, and positively infected cells were determined by X-Gal staining. Cells infected with virus at concentrations below 200 PFU/cell virtually did not show any X-Gal-positive staining. More X-Gal-positive cells were observed with increased viral concentrations above 500 PFU/cell, and the vast majority of cells (Ͼ95%) expressed ␤-Gal after being infected with ϭ5000 PFU/cell (Fig. 2D) . Figure 2A -C show representative photographs of X-Gal staining.
Effects of adenoviral infection of HuH7 cells
A single band, of atomic mass 36 kDa, was present in lysates of mIB␣-infected HuH7 cells, whereas in lysates of cells infected with ␤-Gal no such protein band was observed (Fig. 3A) . As the promoter driving IB␣ expression is also transcriptionally regulated by NF-B (Greten and Karin, 2004; Monks et al., 2004) , ectopic expression of mIB␣ also inhibited endogenous expression of IB␣ (Fig. 3A) , so that the expression level of mIB␣ exceeded endogenous IB␣ expression more than 10-fold. As expected, there was no degradation of mIB␣ after addition of H 2 O 2 (Fig. 3B) . Nuclear translocation of p65 is an essential step for NF-B activation. We therefore examined the effect of mIB␣ on p65 translocation. In naive HuH7 cells, p65 was localized virtually entirely in the cytoplasmic compartment ( Fig. 4A  and C) , and mIB␣ slightly reduced the basal level of p65 expression, as revealed by Western blot (Fig. 4A) . The inhibition of p65 translocation by mIB␣ appeared to be dose dependent (Fig. 4B) , with mIB␣ at 5000 PFU/cell almost completely abrogating p65 translocation. Further studies showed that in cells infected with ␤-Gal, addition of 500 M H 2 O 2 for 24 hr provoked translocation of p65 to the nucleus (Fig.  4D) , and this translocation was profoundly inhibited by mIB␣ (Fig. 4E) . By EMSA, inhibition of NF-B translocation led to reduced DNA binding (Fig. 4F) . In cells infected with ␤-Gal followed by H 2 O 2 treatment, a specific band corresponding to NF-B p65 was evident, whereas in cells infected with mIB␣, NF-B DNA binding was suppressed. Similar to Western blot findings, mIB␣ at 5000 PFU/cell almost completely abolished NF-B DNA-binding activity. These findings for p65 were also observed for p50 (data not shown).
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As H 2 O 2 -induced p65 nuclear translocation occurred in a dose-dependent manner, and cell death was profound after exposure to 1000 M H 2 O 2 , we chose 500 M H 2 O 2 for subsequent experiments unless otherwise specified.
Inhibition of NF-B by mIB␣ downregulates NF-B target genes
To confirm that the introduced mIB␣ functionally blocked NF-B-regulated genes in HuH7 cells, we performed Western blot analysis of intracellular adhesion molecule-1 (ICAM-1). In mIB␣-infected cells compared with ␤-Gal-infected cells, the basal levels of ICAM-1 was reduced (Fig. 4G) , and the H 2 O 2 -induced increase in ICAM-1 was strongly inhibited (Fig. 4H) . Similar results were found with another NF-B target gene, VCAM-1 (data not shown).
Effects of NF-B inhibition on proliferation of HuH7 cells
Inhibition of NF-B by mIB␣ did not, itself, significantly suppress cell proliferation (Fig. 5A) . Exposure of cells to lower concentrations of H 2 O 2 (between 1 and 200 M) did not significantly affect cellular DNA synthesis (Fig. 5B) . However, inhibition of NF-B accentuated such suppression when cells were exposed to higher doses of H 2 O 2 (500 M) (Fig. 5B) .
Effect of NF-B inhibition on viability of HuH7 cells
Because NF-B activation favors cell survival, we investigated whether blocking NF-B sensitized HuH7 cells to oxidative stress-induced cell killing. In cells infected with either ␤-Gal or mIB␣, incubation of cells with H 2 O 2 for 24 hr caused a dose-dependent loss of cell viability. This was substantially greater in cells infected with mIB␣ (Fig. 6) . Because the earlier studies showed that this concentration of H 2 O 2 potently activates NF-B DNA-binding activity, these results are consistent with the proposal that NF-B is an important survival factor for maintaining HuH7 cells.
Apart from H 2 O 2 , we also used bleomycin, a chemotherapeutic agent that causes marked oxidative stress to target cells, to test whether inhibition of NF-B could sensitize the cell-killing effect of this agent. As revealed by WST-1 assay, cells infected with mIB␣ were more sensitive to bleomycin-induced killing as compared with cells infected with ␤-Gal (data not shown).
Effects of NF-B inhibition on apoptosis in HuH7 cells
As shown by TUNEL staining, 500 M H 2 O 2 caused massive apoptotic cell death in HuH7 cells (Fig. 7C) . Blockade of NF-B failed to increase the rate of apoptosis (Fig. 7D) . On the contrary, apoptotic cell death appeared to be suppressed (Fig.  7E ), although the difference between these two groups was not significant. Judging by morphology, cell death in both groups was also via necrosis. More necrotic cells were present in mIB␣-infected cells than in ␤-Gal-infected cells.
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Mechanisms of cell killing in response to oxidative stress and NF-B inhibition
Finally, we investigated the possible mechanisms responsible for apoptotic cell death in response to oxidative stress and NF-B inhibition. We tested whether caspase-3 was activated. As shown in Fig. 8A , caspase-3 was dose dependently activated by 200 and 500 M H 2 O 2 , and blockage of NF-B caused more caspase-3 activation. Western blot confirmed this finding, showing a more marked decrease of procaspase-3 in mIB␣-infected cells treated with H 2 O 2 (Fig. 8B) .
We also measured the expression of two Bcl-2 family proteins: the proapoptotic Bax and anti-apoptotic Bcl-X L . Bax expression was not altered by viral infection alone or viral infection followed by H 2 O 2 (Fig. 8C) . In contrast, the expression of Bcl-X L was suppressed by 500 M H 2 O 2 , and mIB␣ further suppressed its expression (Fig. 8C) .
DISCUSSION
Activation of the ubiquitous transcription factor NF-B is protective against cell death in many cell types, particularly (but not exclusively) by apoptosis (Karin and Lin, 2002) . It is therefore of interest that many cancers, such as breast cancer, lung cancer, and lymphoma (Rayet and Gelinas, 1999) , and HCC (according to other reports), constitutively express high levels of NF-B (Kaufmann and Earnshaw, 2000; Herr and Debatin, 2001; Chiao et al., 2002) . Conversely, several anticancer drugs potently activate NF-B, and resistance of certain cancer cells to apoptosis has been attributed to constitutive activation of NF-B (Chiao et al., 2002; Sato et al., 2003; Panwalkar et al., 2004; Samanta et al., 2004) . In the present study, we found that at least six of eight human HCCs (75%) expressed higher levels of the NF-B Rel protein, p65, than surrounding noncancerous liver, and in at least three of them, this p65 was localized predominantly in the nucleus. The latter finding is consistent with constitutive activation of NF-B. Thus the present results confirmed and extend earlier studies of high-level NF-B in HCC liver and show apparently constitutive activation of NF-B in human HCC. We also found no difference between well and poorly differentiated HCC in terms of NF-B protein expression. This is in agreement with a previous report (Guo et al., 2005) .
Because it is difficult to study the mechanisms and biological implications of NF-B activation in intact human liver, we addressed these issues in an HCC cell line, HuH7, which also expresses high-level constitutive activation of NF-B. In this study, we used mIB␣ (also termed IB␣ superrepressor), transfected via an adenoviral vector, to block NF-B activation, and examined the effect on cell viability, mechanisms of cell death (especially apoptosis), and proliferation. At the doses that were effective in these experiments, mIB␣ could easily be introduced into the HuH7 cells without having any detrimental effects on cell viability or endogenous NF-B. Expression levels of mIB␣ were readily induced up to 10-fold higher than the level of endogenous IB␣. As expected, this protein was not degraded after addition of H 2 O 2 . Further, the expression of endogenous IB␣, which is itself under NF-B regulation, was also inhibited by mIB␣. In untreated HuH7 cells, most p65 is located in the cytoplasm. Introduction of mIB␣ effectively prevented H 2 O 2 -induced p65 translocation to the nucleus, as judged by Western blot and immunofluorescence staining, and confirmed NF-B p65/p50 dimeric binding to DNA by EMSA. Such abrogation of NF-B activation caused the anticipated functional consequences of downregulation of two important downstream target genes, ICAM-1 and VCAM-1.
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Previous studies of patients with HCC have shown a marked increase in circulating (Hyodo et al., 1996) and hepatic (Yoong et al., 1998) expression of these cell adhesion molecules, as well as E-selectin. In the present study, we showed that ICAM-1 is highly expressed in HuH7 cells. However, the relationship between the expression of cell adhesion molecules and cancer development or prognosis remains controversial. It is therefore unclear whether modulation of ICAM-1 and VCAM-1 expression by manipulating NF-B activity would potentially be useful in controlling the local progression of liver cancer, or metastasis from the liver. The human liver is constantly exposed to oxidative stress produced as the result of the metabolic production of reactive oxidative species (ROS), such as hydrogen peroxide, superoxide ion, and hydroxyl radicals. ROS can cause oxidative damage to DNA and is therefore a potential mutagenic factor in cancer formation and, in addition, can modulate cell proliferation and cell death in ways that could promote clonal expansion of preneoplastic foci in the liver. On the other hand, some cancer-therapeutic agents kill cells by inducing oxidative stress in mitochondria, a pathway that is opposed by ROS-induced activation of NF-B. Many apoptotic stimuli, such as calcium ionophore, TNF, interleukin-1, and lipopolysaccharide, can activate NF-B by distinct intracellular pathways, but a common mechanism involves the synthesis of ROS (Schreck et al., 1991) . Thus, NF-B is a redox-sensitive nuclear transcription factor. Studies have shown that raised intracellular H 2 O 2 levels are mechanistically responsible for induction of apoptosis and inhibition of growth in MG132 (an inhibitor of 26S proteasome)-treated HCC cells (Tuvdendorj et al., 2003) as well as in arsenic trioxide-treated acute promyelocytic leukemic cells (Chen et al., 2003) . The role of NF-B and ROS in chemically induced hepatocarcinogenesis was supported in one study (Maeda et al., 2005) .
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In the present study, treatment of HuH7 cells with H 2 O 2 led to dose-dependent cell killing that was enhanced by NF-B inactivation. Cell killing was via both apoptosis and necrosis. The fact that blockade of NF-B activity by mIB␣ potentiated H 2 O 2 -induced cell death via apoptotic and nonapoptotic pathways is consistent with growing evidence that NF-B not only regulates the apoptotic pathways but may also govern pathways that lead to necrosis (Kucharczak et al., 2003) . In addition, necrosis might be secondary to the apoptosis ("necrogenic apoptosis"), occurring in response to apoptotic stimuli (Xu et al., 1998) . It seems increasingly likely that at certain stages of their pathways, and particularly in the liver, where the requirement for ATP to execute apoptosis may be high, these two different types of cell death share the same signaling events.
Apoptosis appeared not to be the major mode of cell death when HuH7 cells were exposed to H 2 O 2 . However, the further accentuation of cell death attributed to NF-B blockade in the face of H 2 O 2 was not apparently by apoptosis. Caspase-3 plays an essential role in apoptosis execution in most cell types, and exposure of HuH7 cells to H 2 O 2 caused a dose-dependent increase in caspase-3 activity. Blocking NF-B further potentiated H 2 O 2 -induced activation of caspase-3. However, caspase-3 can also play a role in necrosis under some circumstances (El-Hassan et al., 2003) , especially when ATP is depleted as may be the case in HuH7 cells exposed to H 2 O 2 . Alternatively, the further accentuation of cell death, which was also not associated with TUNEL-positive cells, could be due to necrosis.
There are many target genes of NF-B, include such antiapoptotic proteins as cIAP1, cIAP2, TRAF1, TRAF2, Bcl-X L , and FLIP, and certain proapoptotic proteins such as Bax, Fas, Fas ligand, TRAIL-R1, and TRAIL-R2 (Wang et al., 1999; Tietze et al., 2000; Heimberg et al., 2001; Sato et al., 2003; Debatin, 2004) . It is therefore possible that activation of NF-B can inhibit or promote apoptosis. Bax is a strong proapoptotic gene whereas Bcl-X L possesses strong antiapoptotic properties. In our study, Bax was not affected by NF-B modulation in HuH7 cells. However, inhibition of NF-B activity appeared to suppress Bcl-X L expression. Therefore, we speculated that diminished expression of Bcl-X L may have contributed to increased apoptosis.
NF-B is important not only in apoptosis pathways, but also as a transcription factor in the signal transduction of the inflammatory response; this is particularly relevant in cancers in which inflammation plays a pivotal role. The relationship between inflammation and cancer has gained extensive attention (Balkwill and Coussens, 2004; Karin and Greten, 2005; Li et al., 2005) . Chronic inflammation has been recognized as an important cause of tumor development, accounting for approximately 20% of human cancer. It has been proposed that NF-B contributes to tumorigenesis through effects on both tumor cells and tumorassociated inflammatory cells (Balkwill and Coussens, 2004) . Inhibition of NF-B in malignant cells would increase susceptibility to apoptosis-inducing agents, through the downregulation of certain antiapoptosis factors such as Bcl-X L , and in inflammatory cells it would inhibit the expression of growth and survival factors such as TNF-␣ and IL-6. Thus, targeting NF-B could be a useful strategy for cancer therapy (Karin and Greten, 2005) .
The effect of NF-B superrepressor in experimental cancer therapy has been demonstrated in several studies. In one study of hepatocarcinogenesis in multidrug resistance-2 gene (MDR2) knockout mice (Pikarsky et al., 2004) , it was found that the inflammatory process triggers hepatocyte NF-B through upregulation of tumor necrosis factor-␣ (TNF-␣) in adjacent endothelial and inflammatory cells. Although inhibition of NF-B in mice by tetracycline-inducible, liver-specific expression of a superrepressor of NF-B did not affect the course of hepatitis, or the early phases of hepatocyte transformation, IB superrepressor-mediated suppression of NF-B did result in the apoptosis of transformed hepatocytes and suppressed progress to hepatocellular carcinoma, suggesting that NF-B may not be required for early-phase cancer development (tumor initiation), but is essential for subsequent tumor promotion. Similarly, inhibition of NF-B by superrepressor reduces the inflammation-induced metastasis of CT26 colon cancer cells to the lungs (Luo et al., 2004) . Our in vitro results support the idea that NF-B superrepressor may be a potentially useful approach in targeting NF-B as a therapeutic tool for certain cancer, especially those malignancies that are closely associated with inflammatory or oxidative stress processes.
One of the aims of cancer therapy is to deprive cancer cells of their growth potential. In this study, we showed that inhibition of NF-B did not, by itself, suppress cell proliferation (as indicated by DNA synthesis) in HuH7 cells. However, blocking NF-B by mIB␣ did enhanced the growth-inhibitory effect of H 2 O 2 , especially when it was used at higher doses. Further studies are needed to clarify what genes are responsible for such growth inhibition.
In conclusion, the current study demonstrated that adenovirus-mediated transfer of mIB␣ is an efficient way to block the NF-B pathway in vitro. The introduced construct is functional in that it blocks NF-B translocation, blocks DNA binding, and inhibits the expression of downstream target genes. Inhibition of NF-B by mIB␣ has the potential to inhibit HuH7 cell proliferation, and oxidative stress can strongly activate the apoptotic cascade in HuH7 cells. These results warrant further studies into the efficacy and mechanisms of NF-B inactivation as a new target for HCC gene therapy. Our preliminary in vivo results have indicated that HuH7 cells infected with mIB␣ showed diminished tumorigenic potential in nude mice. We await the completion of this study.
